상세 정보

underline
Metadata Downloads : dc(xml) or Excel
Cited 0 time in scopus ci

Title 

A comparison of gene expression profiles between primary human AML cells and AML cell line

Authors 

J LeeJ HwangH S KimS KimY H KimS Y ParkK S KimZ Y RyooKyu Tae ChangS Lee

Publisher 

Genetics Society of Japan

Issue Date 

2008

Citation 

Genes and Genetic Systems, vol. 83, no. 0, pp. 339-345

Keywords 

AMLgene expressionSAGEtranslocationmitogen activated protein kinase 1mitogen activated protein kinase 3protein HRASunclassified drugacute granulocytic leukemiachromosome analysis

Abstract 

In acute myeloid leukemia (AML), hematologic malignancies are characterized by recurring chromosomal abnormalities. Chromosome translocation t(9; 11)(p22; q23) is one of the most common genetic aberrations and results in the formation of the MLL-AF9 fusion gene that functions as a facilitator of cell growth directly. In order to study this type of AML, the cell lines with cytogenetically diagnosed t(9; q23), such as Mono Mac 6 (MM6), have been widely used. To examine whether there is any difference in gene expression between the primary human t(9; 11) AML cells and MM6 cell line, genome-wide transcriptome analysis was performed on MM6 cell line using SAGE and the results were compared to the profile of primary human t(9; 11) AML cells. 884 transcripts which were alternatively expressed between MM6 cells and primary human t(9; 11) cells were identified through statistical analysis (P < 0.05) and 4-fold expression change. of these transcripts, 830 (94%) matched to known genes or EST were classified by functional categories (http://david.abcc. ncifcrf.gov/). The majority of alternatively expressed genes in MM6 were involved in biosynthetic and metabolic processes, but HRAS, a protein that is known to be associated with leukemogenesis, was expressed only in MM6 cells and several other genes involved in Erk1/Erk2 MAPK pathway were also over-expressed in MM6. Therefore, since MM6 cell line has a similar expression profile to primary human t(9; 11) AML in general and expresses uniquely a strong Erk1/Erk2 MAPK pathway including HRAS, it can be used as a model for HRAS-positive t(9; 11) AML.

ISSN 

1341-7568

Link 

http://dx.doi.org/10.1266/ggs.83.339

Appears in Collections

1. Journal Articles > Journal Articles

Registered Date

2017-04-19


There are no files associated with this item.
qrcode

FusionCharts.
DSpace Software Coptright(c) 2010 MIT and Hewleft-Packard  /  KRIBB-REPOSITORY ( Email:jakim@kribb.re.kr)